{
    "key_points": [
        "Recent clinical trials have proven the effectiveness and safety of COVID-19 vaccines.",
        "A new study published in The New England Journal of Medicine confirms these findings in a real-world setting.",
        "Conducted by researchers from Clalit Research Institute, Harvard Medical School, and the Harvard T.H. Chan School of Public Health, the study analyzed data from nearly 2 million individuals in Israel.",
        "The research shows few adverse events associated with the Pfizer/BioNTech BNT162b2 mRNA vaccine. Myocarditis was identified as a rare side effect with a rate of 2.7 excess cases per 100,000 vaccinated people.",
        "The risk of myocarditis and other serious conditions was significantly higher among unvaccinated individuals infected with SARS-CoV-2.",
        "This study is likely to help with vaccine hesitancy issues by offering comprehensive safety information, according to Ben Reis, HMS assistant professor of pediatrics.",
        "Ran Balicer, director of the Clalit Research Institute, emphasized the safety of mRNA vaccines and the higher risks of 'natural' coronavirus morbidity.",
        "The study confirms and complements findings from the Pfizer/BioNTech phase 3 randomized clinical trial.",
        "A parallel analysis assessed 25 potential adverse events in vaccinated versus unvaccinated individuals.",
        "Adverse events moderately associated with vaccination included lymph node swelling, appendicitis, and reactivation of herpes zoster, but these were rare."
    ],
    "spokespersons": [
        "Ben Reis (HMS assistant professor of pediatrics, director of the predictive medicine group, Computational Health Informatics Program at Boston Children's)",
        "Ran Balicer (director, Clalit Research Institute, Chief Innovation Officer for Clalit, chairman of Israel's National Expert Advisory Team on COVID-19 response)"
    ],
    "article_type": "general reporting",
    "dateline": "",
    "audience": "general public",
    "stance": "neutral"
}